**Biocon Biologics Crosses 100 Million Insulin Cartridges Supplied in Malaysia**

**Key Highlights:** * **Milestone Achieved**: Over **100 million cartridges** of **recombinant human insulin (rh-insulin)** supplied to Malaysia’s Ministry of Health since 2016. * **Impact**: Over **345,000 diabetes patients served**. * **Strategic Partnership**: Collaboration with **Duopharma Biotech** and the **Malaysian government** highlights a successful public-private model. * **Manufacturing Excellence**: Biocon’s **USD 600 million Johor facility** is Malaysia’s **first and largest integrated insulin plant**, producing a wide range of insulins. * **Recognition**: Listed in the **Malaysia Book of Records**. * **Global Reach**: Biocon is among the **Top 3 global players** in rh-Insulin and Insulin Glargine; over **9.2 billion doses** supplied worldwide. * **Mission**: Committed to serving **1 in 5** insulin-dependent patients globally.